GlaxoSmithKline set to complete $20 billion Novartis asset swap next week - (London South East via NewsPoints Desk)

  • GlaxoSmithKline disclosed that it hopes to complete its $20-billion asset swap with Novartis next week after obtain regulatory clearances for the transaction, as reported London South East Wednesday.
  • In the agreement, which was initially announced in April last year, GlaxoSmithKline is acquiring Novartis' vaccines business while divesting its oncology division to the Swiss company.
  • The two drugmakers will also a consumer health joint venture.

To read more NewsPoints articles, click here.

Reference Articles